𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tolerability of Naltrexone in Treating Older, Alcohol-Dependent Patients

✍ Scribed by David Oslin; Joseph C. Liberto; John O'Brien; Stacy Krois

Book ID
109061547
Publisher
Informa plc
Year
1997
Tongue
English
Weight
342 KB
Volume
6
Category
Article
ISSN
1055-0496

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety, tolerability, and feasibility of
Safety, tolerability, and feasibility of high-dose naltrexone in alcohol dependence: an open-label study
✍ Gihyun Yoon; Suck Won Kim; Paul Thuras; Joseph Westermeyer πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 90 KB

Objective Prior trials testing standard-dose naltrexone (50 mg/day) have generated mixed results in the treatment of alcohol dependence. The purpose of this study was to evaluate the short-term safety, tolerability, and feasibility of high-dose naltrexone (150 mg/day) for treating alcohol-dependent

Safety and tolerability of gamma-hydroxy
Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependent patients
✍ Franco BeghΓ¨; Maria Teresa Carpanini πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier Science 🌐 English βš– 40 KB

Gamma-hydroxybutyric acid (GHB) has been in clinical use in Italy since 1991 for treatment of alcohol dependence. Results of phase III and phase IV studies have shown that the drug is effective and well tolerated in the treatment of alcohol withdrawal syndrome and in reducing alcohol consumption and